Last updated: April 18, 2025
Sponsor: Holy Family Hospital, Nazareth, Israel
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
programmed intermittent Bolus epidural analgesia
continuous epidural infusion
Clinical Study ID
NCT06494280
297\2024 HFH
Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Nulliparous women
Term pregnancy
Singleton
Vertex presentation
Latent phase (cervical dilatation <6 cm)
Epidural analgesia request
Visual Analogue Scale score > 40
Exclusion
Exclusion Criteria:
Estimated fetal weight > 4 kg
Intra uterine fetal death
Drug sensitivity
Anomalous fetus
Contraindication for epidural analgesia
Study Design
Total Participants: 240
Treatment Group(s): 2
Primary Treatment: programmed intermittent Bolus epidural analgesia
Phase:
Study Start date:
September 10, 2024
Estimated Completion Date:
March 31, 2026
Study Description
Connect with a study center
Holy Family Hospital
Nazareth,
IsraelActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.